12月5日 - ** 制药商Intensity Therapeutics INTS.O股价盘前上涨8.6%至50美分
** 该公司从纳斯达克交易所获得180天的延期，以满足最低1美元股价的要求
** 截止日期定为2026年6月1日；该公司表示，股价必须连续10天保持在1美元以上
** 公司继续进行 INT230-6 治疗软组织肉瘤和乳腺癌的后期试验
** INT230-6 注射到肿瘤中可杀死癌细胞并引发免疫反应 - INTS
** 截至上次收盘，该股今年累计下跌 ~74
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.